Opening Bell Analyst Calls Briefing for Friday, October 28, 2022
Here is a look at analysts' research calls before Friday's opening bell.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Amplify Energy (AMPY) upgraded to Buy from Neutral at ROTH Capital; tgt $12
> Customers Bancorp (CUBI) upgraded to Buy from Neutral at DA Davidson; tgt raised to $44
> Royal KPN (KKPNY) upgraded to Outperform from Neutral at Exane BNP Paribas
Downgrades:
> DigitalOcean (DOCN) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> Globe Life (GL) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $114
> Kearny Financial (KRNY) downgraded to Neutral from Buy at Compass Point; tgt lowered to $11
> Norsk Hydro (NHYDY) downgraded to Underweight from Neutral at JP Morgan
> ResMed (RMD) downgraded to Neutral from Buy at Citigroup
> Teck Resources (TECK) downgraded to Neutral from Buy at Citigroup
> XPeng (XPEV) downgraded to Sell from Buy at Citigroup; tgt $3.18
Others:
> Alithya (ALYA) initiated with a Sector Perform at National Bank Financial
> AST SpaceMobile (ASTS) initiated with a Buy at B. Riley Securities; tgt $15
> Cresco Labs (CRLBF) assumed with a Buy at BTIG Research
> Curaleaf (CURLF) assumed with a Buy at BTIG Research
> Green Thumb (GTBIF) assumed with a Buy at BTIG Research
> Mirati Therapeutics (MRTX) initiated with a Neutral at B. Riley Securities; tgt $72
Research calls posted earlier this morning are available here and here.
Contact [email protected] for any questions or corrections.